Personalized weaning strategy for patients on mechanical ventilation
Effect of a Personalized Weaning Strategy on Weaning Success
NA · University Hospital, Clermont-Ferrand · NCT05719194
This study tests if a personalized approach to help patients on mechanical ventilation breathe on their own can work better than standard care in intensive care units.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 750 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Clermont-Ferrand (other) |
| Locations | 9 sites (Bordeaux and 8 other locations) |
| Trial ID | NCT05719194 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a personalized weaning strategy for patients undergoing mechanical ventilation in intensive care units. It compares standard care practices with a protocolized approach that includes daily assessments of weaning criteria and tailored weaning trials based on individual risk factors for weaning-induced pulmonary edema. Patients will either follow the usual care or the personalized strategy, which utilizes either pressure support ventilation or T-piece based on their specific health conditions. The goal is to improve weaning success rates and reduce the need for re-intubation.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who have been on invasive mechanical ventilation for more than 24 hours and meet specific weaning criteria.
Not a fit: Patients who are not stable enough for weaning or have planned surgeries within 72 hours may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance the weaning process from mechanical ventilation, leading to better patient outcomes and reduced complications.
How similar studies have performed: Other studies have explored various weaning strategies, but this personalized approach is relatively novel and aims to address specific risk factors associated with failed extubation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria : all patients ≥ 18 y.o admitted to the ICU, under invasive mechanical ventilation for more then 24 hours and fullfilling the following weaning criteria : * Resolution or improvement of the condition that led to intubation, as judged by the clinician in charge of the patient. * Hemodynamic stability, defined as systolic blood pressure between 90 and 160 mmHg, heart rate less than 140 beats/min, without or with low doses of vasopressors. * Glasgow score of 13 or greater and Richmond Agitation-Sedation Scale (RASS) score between -1 and +1. * Respiratory stability defined as: oxygen saturation \> 90% with inspired oxygen fraction ≤ 0.5 and PEEP ≤ 8 cmH2O, respiratory rate \< 35/min, spontaneous tidal volume \> 5 mL/kg, and peak inspiratory pressure ≤ 15 cmH2O. * Few secretions (\< 3 aspirations in the past 8 hours). * Effective cough. * Negative leak test (\>100 mL or \>10%). * No surgery planned within 72 hours. * Patients with a social security plan. Exclusion Criteria: * Acute cerebral pathology requiring admission to intensive care and/or mechanical ventilation with tracheal intubation for neurological reasons (Glasgow score \<13 at the time of intubation or CT scan abnormality): hemorrhagic stroke without or with vascular malformation (aneurysm, arterio-venous malformation...), ischemic stroke, head trauma, cerebral anoxo-ischemia after cardiac arrest. * Tetraplegic or paraplegic patients with lesion level higher than D8. * Peripheral neuromuscular pathology (underlying myopathy or myasthenia). * ICU's Neuromyopathy. * Tracheostomy. * Patients with a decision of non-reintubation or terminal intubation. * Pregnant or lactating women. * Patients already included in this study. * Patients under guardianship, curatorship or safeguard of justice.
Where this trial is running
Bordeaux and 8 other locations
- CHU de Bordeaux — Bordeaux, France (RECRUITING)
- CHU de Clermont-Ferrand — Clermont-Ferrand, France (RECRUITING)
- CHU de Grenoble — Grenoble, France (RECRUITING)
- CHU de Lille — Lille, France (RECRUITING)
- CHU de Lyon - Hôpital Lyon Sud — Lyon, France (RECRUITING)
- CHU de Montpellier — Montpellier, France (RECRUITING)
- CHU de Nantes — Nantes, France (RECRUITING)
- CHU de Saint-Etienne — Saint-Étienne, France (RECRUITING)
- CHU de Toulouse — Toulouse, France (RECRUITING)
Study contacts
- Study coordinator: Lise Laclautre
- Email: llaclautre_perrier@chu-clermontferrand.fr
- Phone: +33473754963
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Weaning, Mechanical Ventilation, Intubation, WIPO, Extubation, Spontaneous Breathing Trial, T-piece, Pressure Support Ventilation